文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

亚洲不同国家财富水平ICU脓毒症的流行病学、管理与结局

Epidemiology, Management, and Outcomes of Sepsis in ICUs among Countries of Differing National Wealth across Asia.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01
一句话结论亚洲ICU脓毒症患病率22.4%,住院死亡率32.6%,抗菌药物延迟超过3小时与死亡率增加独立相关(aOR 2.53)。

该前瞻性点患病率研究纳入22个亚洲国家/地区386个成人ICU,在2019年四个季节各选一天招募因脓毒症入ICU的成年患者。ICU脓毒症总患病率为22.4%(低收入/中低收入国家/地区20.9%、中高收入国家/地区24.5%、高收入国家/地区21.3%,P<0.001)。住院死亡率32.6%,多变量广义混合模型分析显示低收入/中低收入国家/地区死亡率较高收入国家/地区 marginally 显著升高(aOR 1.84,95%CI 1.00-3.37,P=0.049)。1小时脓毒症集束化治疗依从率21.5%,3小时依从率36.6%;抗菌药物延迟超过3小时是唯一与死亡率增加独立相关的要素(aOR 2.53,95%CI 2.07-3.08,P<0.001)。

要点

  • 亚洲ICU脓毒症总患病率22.4%,低收入/中低收入、中高收入、高收入国家/地区分别为20.9%、24.5%、21.3%(P<0.001)。
  • 住院死亡率32.6%;校正混杂后低收入/中低收入国家/地区死亡率较高收入国家/地区 marginally 显著升高(aOR 1.84,95%CI 1.00-3.37,P=0.049)。
  • 1小时脓毒症集束化治疗依从率21.5%(低收入/中低收入26.0%、中高收入22.1%、高收入16.2%,P<0.001)。
  • 3小时集束化治疗依从率36.6%(低收入/中低收入39.3%、中高收入32.8%、高收入38.5%,P=0.001)。
  • 抗菌药物延迟超过3小时是唯一与死亡率增加独立相关的要素(aOR 2.53,95%CI 2.07-3.08,P<0.001)。

适用人群与场景

  • 22个亚洲国家/地区的386个成人ICU中因脓毒症入院的成年患者,于2019年四个季节各选一天招募。

处置流程与药物剂量

  • 脓毒症集束化治疗包括抗菌药物给药、血培养和乳酸测量;原文报告1小时依从率21.5%、3小时依从率36.6%。

红旗征与不能漏的情况

  • 抗菌药物延迟超过3小时是唯一与死亡率增加独立相关的要素(aOR 2.53,95%CI 2.07-3.08,P<0.001)。

研究设计与关键结果

  • 前瞻性点患病率研究,纳入22个亚洲国家/地区386个成人ICU,于2019年四个季节各选一天招募因脓毒症入院的成年患者。
  • ICU脓毒症总患病率22.4%;低收入/中低收入国家/地区20.9%、中高收入国家/地区24.5%、高收入国家/地区21.3%(P<0.001)。
  • 低收入/中低收入国家/地区患者更年轻、疾病严重程度更低。
  • 住院死亡率32.6%;多变量广义混合模型分析显示低收入/中低收入国家/地区较高收入国家/地区 marginally 显著升高(aOR 1.84,95%CI 1.00-3.37,P=0.049)。
  • 1小时集束化治疗依从率21.5%(低收入/中低收入26.0%、中高收入22.1%、高收入16.2%,P<0.001);3小时依从率36.6%(低收入/中低收入39.3%、中高收入32.8%、高收入38.5%,P=0.001)。
  • 抗菌药物延迟超过3小时是唯一与死亡率增加独立相关的要素(aOR 2.53,95%CI 2.07-3.08,P<0.001)。

证据类型、等级与局限

  • 前瞻性点患病率研究;临床试验注册号CTRI/2019/01/016898。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,抗菌药物延迟超过3小时与死亡率增加相关,脓毒症集束化治疗依从率仍低。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Directly comparative data on sepsis epidemiology and sepsis bundle implementation in countries of differing national wealth remain sparse. Objectives: To evaluate across countries/regions of differing income status in Asia 1) the prevalence, causes, and outcomes of sepsis as a reason for ICU admission and 2) sepsis bundle (antibiotic administration, blood culture, and lactate measurement) compliance and its association with hospital mortality. Methods: A prospective point prevalence study was conducted among 386 adult ICUs from 22 Asian countries/regions. Adult ICU participants admitted for sepsis on four separate days (representing the seasons of 2019) were recruited. Measurements and Main Results: The overall prevalence of sepsis in ICUs was 22.4% (20.9%, 24.5%, and 21.3% in low-income countries/regions [LICs]/lower middle-income countries/regions [LMICs], upper middle-income countries/regions, and high-income countries/regions [HICs], respectively; P < 0.001). Patients were younger and had lower severity of illness in LICs/LMICs. Hospital mortality was 32.6% and marginally significantly higher in LICs/LMICs than HICs on multivariable generalized mixed model analysis (adjusted odds ratio, 1.84; 95% confidence interval, 1.00-3.37; P = 0.049). Sepsis bundle compliance was 21.5% at 1 hour (26.0%, 22.1%, and 16.2% in LICs/LMICs, upper middle-income countries/regions, and HICs, respectively; P < 0.001) and 36.6% at 3 hours (39.3%, 32.8%, and 38.5%, respectively; P = 0.001). Delaying antibiotic administration beyond 3 hours was the only element independently associated with increased mortality (adjusted odds ratio, 2.53; 95% confidence interval, 2.07-3.08; P < 0.001). Conclusions: Sepsis is a common cause of admission to Asian ICUs. Mortality remains high and is higher in LICs/LMICs after controlling for confounders. Sepsis bundle compliance remains low. Delaying antibiotic administration beyond 3 hours from diagnosis is associated with increased mortality. Clinical trial registered with www.ctri.nic.in (CTRI/2019/01/016898).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Li A, Ling L, Qin H, et al. Epidemiology, Management, and Outcomes of Sepsis in ICUs among Countries of Differing National Wealth across Asia. Am J Respir Crit Care Med. 2022. PMID: 35763381. doi:10.1164/rccm.202112-2743OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。